Skip to content
★ Sign in to follow
GV

Ganesh Venkataraman Kaundinya

Momenta Pharmaceuticals Inc
Total declarations
107
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (90 ops.)
€2.0M

Latest filing published 23 Aug 2018 for MOMENTA PHARMACEUTICALS INC, €14k.

Filing timeline

BuySale
Ganesh Venkataraman Kaundinya

Insider track record

Disclosed buys
0
Disclosed sells
90
Signal history

Ganesh Venkataraman Kaundinya: trading record in brief

All filings by Ganesh Venkataraman Kaundinya on record concern Momenta Pharmaceuticals Inc. Over a trading history stretching from 28 February 2012 to 21 August 2018, the count stands at 107 filings.

Every open-market trade on record is a sale: 90 sales worth €2.0M. The rest of the record consists of 7 share grants and 9 option exercises. 2018 to date brings no purchases and 11 sales.

The latest filing, published on 23 August 2018, reports an open-market sale of €14k in Momenta Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Ganesh Venkataraman Kaundinya

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations89 total

25 of 89 declarations